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1050-l 00 Prediction of Major Coronary Events in Stable Angina: 
The IONA Study 
Alex D. McMahon, Henry J. Dargie, Ian Ford, Stewart HiIlls, Kim M. Fox, University of 
Glasgow, Glasgow, United Kingdom, Royal Brompton Hospital. London, United Kingdom 
Background: The Impact Of Nicorandil in Angina study (ION) was a randomized con- 
trolled trial in 5126 patients with stable angina. Nicorandil, a potassium channel activator, 
reduced the incidence of the primary end point (CHD death, non fatal Ml or unplanned 
hospitalization for anglna) by 17% HR 0.83 (0.72, 0.97), p = 0.014 and is the first anti 
angina1 agent to be shown to improve clinical outcome in stableangina. 
Methods: We interrogated the IONA database to identify factors related to outcome in 
order to inform clinical decision making about prognosis. Candidate factors were age. 
gender, Canadian Cardiovascular Society Functional status (CCSF). smoking, systolic 
blood pressure (SBP). heart rate, body mass index and histories of myocardial infarction, 
coronary artery bypass graftrng (CABG), hypertension, diabetes, left ventricular hypertro- 
phy on EKG and left ventricular systolic dysfunction. These were entered Into a Cox pro- 
portional hazards model 
Results: All risk factors with the exception of gender, SBP, CABG, diabetes and hyper- 
tension were univariate predictors of the primary end point. The strongest multivariate 
predictors of outcome were, in descending order of Importance. CCSF score IV, HR 5.49 
(3.10, lO.OO), p < 0.001; CCSF score Ill, HR 2.13 (1.67, 2.7+), p < 0.001; CCSF II, HR 
1.25 (1.04, 1.51). p = 0.021; previous MI, HR 1.54 (1.30, 1.83), p < 0.001; current smok- 
ing,HR1.32(1.10,1.60),p=0.004;age,HR1.05(1.00, l.ll),p=O.O35;treatmentwith 
nicorandil, HR 0.82 (0.71, 0.95), p = 0.009. 
Conclusions: In the presence of medication which reduces major coronary events the 
profile of risk factors in patrents with stable anglna changes considerably. Traditionally 
strong factors including previous CABG, male gender, hypertension and diabetes were 
no longer even univanately predictive of outcome. By far the strongest predictor was clin- 
ical severity of angina (CCSF score) while smoking and previous Ml also remain Inde- 
pendently though less predictive than symptoms. These data could have an important 
influence on clinical assignment of nsk and therefore on future clinical practice. 
1050-101 Cumulative Infectious Burden (but Not Any Single Past 
Infection) Is Interrelated With Traditional Risk Factors to 
Cause Coronary Artery Disease 
Einat Cotter-Metzkor. Ricardo Krakover. Gad Cotter Miriam Ben-Yaakov, Tzllia 
Lazarovich, Zehava ChewLevy, Ronit Zaidenstein,hlomo Fytlovich, Ida Boldur. Ahuva 
Golik, Assaf-Harofeh Medical Center, Zerifin, Israel 
The causative role of past infections in the pathogenesis of coronary artery disease 
(CAD) is uncertain. 
Methods: We evaluated 179 consecutive patients, admitted electively for coronary 
angiography, for traditional atherosclerotic risk factors, serologic markers for prior infec- 
tions with Chlamydia pneumonia, Hellcobacter pylori, Cytomegalovirus (CMV). Epstew 
Barr virus (EBV), Mycoplasma pneumonia, Hepatltls A virus (HAV), Hepatitis B virus 
(HBV). Hepatitis C virus (HCV), fibrinogen and ferritin. Patients underwent coronary 
angiography. Patients with CAD were compared to patients with angiograpicaly normal 
coronary arteries (NCA). 
Results: Serologic markers of past infection with Chlamydia pneumonia (IgG, IgA) and 
serologic marker of past infection with Helicobacter pylorl (IgG) were more prevalent in 
the CAD patients group compared to NCA patients. However, after adjustment for tradi- 
tlonal risk factors none of the serologic markers for infectious agents remained an inde- 
pendent risk factor for CAD, while the cumulative effect of numerous past infections was 
found to progressively increase the risk for CAD. Having 3-4 positive serologic markers 
confers a risk for CAD of 7.5 (Cl 1.4-39.1) compared having O-2 serologic markers. Hav- 
ing more than 5 serologic markers was shown to confer an even greater nsk for CAD 
(16.8; Cl 2.8-99). 
Conclusions: The cumulative infections burden rather than any specific infection is 
related to an increased risk of coronary artery disease, implying that increased inflamma- 
tory burden over long periods of time might contribute to the pathogenesis of ischemic 
heart disease. 
1050-l 02 Relation of Testosterone With Inflammatory Cytokines 
in Men With Coronary Artery Disease 
Peter J. Puqh Chris J. Malkin, Paul D. Morns, Joanne Nettleship, Richard D. Jones, T. 
H. Jones, Kevin S. Charmer, Royal Hallamshire Hospital, Sheffield, United Kingdom, 
University of Shefheld Medrcal School, Sheffield, Umted Kingdom 
Background: Various cytokines have been identified as mediating the inflammatory pro- 
cess of atherosclerosis. Testosterone is known to possess anti-inflammatory properties 
and has been suggested as a therapy for some inflammatory conditions. Men with coro- 
nary artery disease have reduced levels of testosterone. Animal studies suggest that 
androgens may retard the progresslon of atherosclerosis. The mechanism of benefit is 
unknown but could involve immune modulation. In this study, we examined the relation 
between circulating levels of testosterone and inflammatory cytokines in men with estab- 
lished coronary artery disease. 
Methods: Seventy five men with angiographically proven coronary artery disease (z 
70% stenosis in 2 1 coronary artery) were studied. Blood samples were taken between 8 
and 9.30am. Serum was removed by centrifugation and stored at -80” C until assayed. 
Serum levels of total and bio-available testosterone were measured, together with the 
pro-inflammatory cytokines tumour necrosis factor-a (TNF), interleukin- (II-) lp and 11-6, 
and the anti-inflammatory cytokine II-IO. Compansons were made between eugonadal 
men and those with total testosterone level 5 7.5nmollL or bio-available testosterone 5 
2 5nmol/L, using the Mann Whitney U test. 
Results: Eighteen subjects had low androgen levels. Compared with eugonadal sub- 
jects, levels of II-1p were significantly elevated (516 + 127fg/ml v 253 -t 42fg/ml, 
p=O.O30). Levels of TNF, II-6 and II-10 did not differ significantly between groups (TNF 
2.59 * 0.75pglml ~2.35 + 0.34pg/ml, p=O.785; II-6 3.58 * 0.6lpg/ml ~6.66 f 2.72pg/ml. 
p=O.l90; II-IO 2.42 * l.O4pg/ml Y 1.68 r O.lSpg/ml, p=O.613). There was a significant 
inverse relationship of both total and bio-available testosterone with II-lp (rs-0.262, 
p=O.O24; re-0.283, p=O.O15), but not with other cylokines. 
Conclusion: In men with coronary artery disease, low testosterone levels are associated 
with pro-inflammatory cytokine activation. Whether this represents cause or effect is 
unclear but the data may support a rationale for androgen replacement therapy in men 
with coronary artery disease. 
1050-l 03 Prevalence of Hypogonadism in Men With Coronary 
Artery Disease 
Peter J. Push, Chris J. Malkln, Paul D. Morris, Sonia Asif. Richard D. Jones, T. H. Jones, 
Kevin S. Charmer, Royal Hallamshlre Hospital, Sheffield, United Kingdom, University of 
Sheffield Me&al School, Sheffield, United Kingdom 
Background: Low serum testosterone level has been associated with numerous nsk 
factors for coronary artery disease (CAD) and men with CAD have lower androgan levels 
than controls. Testosterone administration has a beneficial effect on various coronary 
risk factors and has been shown to reduce symptoms and ischaemia in men with angina, 
with greatest effect in hypogonadal men. Men with CAD therefore represent a population 
prone to testosterone deficiency who may especially benefit from hormone treatment. 
The purpose of this study was to determine the size of the problem. Methods: Blood 
samples were taken between 0800 and 0930hours from 900 men with proven CAD (t 
70% stenosis in t 1 epicardIaI coronary artery). 69 subjects with evidence of inflamma- 
tion or elevated C-reactive protein were excluded. Serum levels of total (TT) and bio- 
available testosterone (BT) were measured in the remaining 831. Hypogonadism was 
defined as n < 7.5nmoWL and I or BT 5 2.5nmolIL. Results: TT was low In 117 subjects 
(14.1%). BT was low I” 165 (19.9%). 194 had low TT and / or BT. The prevalence of 
hypogonadism therefore was 23.4%. It was more frequent In the obese (BMl>30) (33.3% 
v 19.1% x 2=15.8. pcO.0001) and less frequent in smokers (13.8% ~24.7% x ‘=5.5, 
~~0.02). There was a significant relationship of hypogonadism with age (figure). 
Conclusion: Using strict criteria, nearly a quarter of men with significant CAD are hypog- 
onadal. Further trials are required to determine the benefits and safety of hormone 
replacement in these patients. 
1050-104 Which Features of the Metabolic Syndrome Predict the 
Presence of Angiographic Coronary Artery Disease? 
Sandra P. Reyna, Joseph 8. Muhlestein, John F. Carlquist, Dale G. Renlund, Donald L. 
Lappb, Tami L. Bair, Robert R. Pearson, Benjamin D. Home, Chloe A. Allen Maycosk, 
Stephanie V. Moore, Jeffrey L. Anderson, LDS Hospital, Salt Lake City, UT, University of 
Utah, Salt Lake City, UT 
Background: The metabolic syndrome (MS), a cluster of vascular risk factors, is growing 
in prevalence. The Adult Treatment Panel Ill Guidelines provide a uniform clinlcal defini- 
tion of MS but offer no information about the individual and combined predictive value 
(PV) of its components for CAD. 
Methods: We tested the PV of the MS and its components for CAD in a consecutive 
series of consenting, prospectwely entered subjects undergoing coronary angiography 
for suspected cardiac disease. Acute Ml at presentation was excluded. Components of 
the MS were assessed at the time of study entry (angiography) and included: 1) fasting 
glucose (FG) 2110 mg/dL, 2) triglyceride (TG) 2150 mg/dL, 3) high density lipoprotein 
cholesterol (HDL) ~40 mg/dL in men or ~50 mg/dL in women. and 4) systolic blood pres- 
sure (SBP) 2130 and/or diastolic (D) BP 285 mmHg. MS was defined as 23 features. 
Waist circumference was not captured in the database, so body mass index (BMI; >27 
kgim2) was explored as a surrogate fifth measure. Angiographic assessment was 
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blinded to presence of MS. Associations were assessed by logistic regression. 
Results: The study included 3,528 subjects; 67% were male; age averaged 63+12 years; 
57.7% had significant (270% stenosis), 11 .l% mild/moderate, and 31 .O% no CAD (~10% 
stenosis). MS was present in 48% of patients; specifically, 39% had high FG; 52% high 
TG; 71% low HDL; 76% high S/DBP; and 58% high BMI. MS predicted increased risk of 
significant CAD (odds ratio [OR] of significant vs. no CAD= 1.40, 95% Cl 1.21-1.62, 
p<O.OOl). High FG (OR=l.91, Cl 1.63223, p<O.OOl) and low HDL (O&1.38. Cl 1.18- 
1.62, pcO.OOl), but not TG, BP, or BMI, were individually predictive of CAD. In multivari- 
able modeling, CAD was predicted by age, gender, high FG (OtXl.75, Cl 1.48-2.06), 
and low HDL (O&1.45, Cl 1.22-1.72)(all p<O.OOl). Similar results (with somewhat 
greater OR for FG, HDL) were found when restricting analysis to younger subjects 
(malesc55 years, females ~65 years). 
Conclusion: In a large, prospective observational study, the MS was predictive of CAD, 
and PV was carried by high FG and low HDL. FG and HDL deserve particular attention in 
risk factor assessment and prevention in subjects at risk for CAD. 
channel. KA~p channel is also located in pancreas 0 cells. K,,, channel in pancreas 8 
cells is closed by glucose and regulates insulin release. 
Purpose. This study was undertaken to assess the interaction between acute hypergly- 
cemia and ischemic preconditioning in patients with AMIMethods. We studied 549 
patients with a first anterior wall AMI who underwent coronary angiography within 12 
hours after the onset of AMI. Acute hyperglycemia was considered to be present if 
patients had plasma glucose21 1 .l mmolJL (200 mgldl) on hospital admission. Prodromal 
angina was defined as angina episode(s) occurring within 24 hours before the onset of 
AMI. Serial measurements of left ventricular ejection fraction (LVEF) were obtained in 
434 patients (79%) before reperfusion therapy and before discharge. 
Aesulb. In 377 patients without acute hyperglycemia, prodromal angina was associated 
with significantly larger Improvement of LVEF (10.1*13.6% vs 5.9+13.3%, p=O.O15) and 
lower 30.day mortality (0% (95% Cl O-3.0) vs 6.7% (4.2-10.5). p=O.OOl). However, in the 
presence of acute hyperglycemia (n=172), there was no significant difference in the 
change in LVEF (5.6+9.9% vs 5.4+13.3%, p=O.94) and 30.day mortality (8.1% (95% Cl 
3.5-17.5) vs 8.2% (4.4-14.8), pEO.98) between patients with prodromal angina and 
patients without. Multivariate analysts showed that prodromal anglna was an mdepen- 
dent predictor of predischarge LVEF in patients without acute hyperglycemia (p=O.O19) 
and not in patients with acute hyperglycemia (p=O.96). 
Conclusion Acute hyperglycemia abolished ischemic preconditionmg effect of prodro- 
mal angina. Our findings may provide a potentlal explanation for the adverse outcome of 
patients with AMI and acute hyperglycemia. 
3:15 p.m. 
1050-l 05 The Medicine, Angioplasty, or Surgery Study (MASS II 
Registry): A Comparison of Diabetic and Nondiabetic 
Patient’s Outcome in Medical Therapy, Coronary 
Angioplasty, and Bypass Surgery During the First Year 
Follow-Up 
Paula R. Soares, Whady Hueb, Bernard J. Gersh, Desiderio Favarato, Luiz M. Cesar. 
Protasio L. Luz. Seraio A. Oliveira. Jose F. Ramires, Heart Institute Medical School 
University of Sao P&lo. Sao Paula, Brazil, Mayo Clinic, Rochester, MN 
Diabetes is known to have a worse prognosis among patients with coronary artery dis- 
ease. In MASS II Registry we compared medical treatment (MT), surgety (CABG) and 
angioplasty (PCI) in patients with multivessel coronary disease. The present study com- 
pared the one-year outcome of the patients divided in two subgroups: diabetic (D) and 
non-diabetic (ND) patients in each of the therapeutic options. 1080 patients were treated 
with CABG (451), PCI (305) and MT (324). The primaly end point was considering as the 
composite events (CE) of cardiac-related deaths, myocardial infarction (Ml) and new 
revascularization (NR) in the first year of follow-up. The results are presented in the table 
1. 
Conclusion: In MASS II Registry during the first year follow-up study there were no statis- 
tical differences in the frequency of composite events between diabetic and non-diabetic 
patients in each of the three therapeutic groups. On the other hand, when outcomes 
were compared among patients undergoing PCI, CABG or MT, there was a statistically 
significant benefit for CABG on the therapy in diabetic patients.. 
Table I 
Group 
PCI 
N Death% Ml % NR % CE % 
D 75 5.3 2.7 8.0 16.0 
ND 230 2.6 6.5 10.9 20.0 
Total 305 3.3 5.6 10.2 19.0 
CABG D 154 3.9 0.6 0.0 4.5’ 
ND 297 2.7 1.0 0.3 4.0 
Total 451 3.1 0.9 0.2 4.2 
MT D 115 5.2 1.7 6.1 13.0 
ND 209 1.4 1.9 5.7 9.1 
Total 324 2.8 1.9 5.9 10.5 
*CABG “s MT “s PCI, p=O.O028 
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1068A-MP-204 Impact of Diabetes on Clinical, Echocardiographic, and 
Electrocardiographic Characteristics of Myocardial 
Infarction 
Costantlna Manes Marc A. Pfeffer. John D. Rutherford, Sally Greaves, Jean-Lucien 
Rouleau, Scott D. Solomon, BrIgham &Women’s Hospital, Boston, MA 
Background Diabetes mfluences the clinical presentation and course of acute myocar- 
dial infarction (AMI). We investigated the Impact of diabetes on clinical, echocardlo- 
graphic and electrocardiographic characteristics of 272 pts with Q-wave anterior AMI 
enrolled in the Healing and Early Afterload Reducing Therapy (HEART) Trial Methods: 
Patients underwent ECG testing within 24h (baseline) and at predischarge (median day 
7) after AMI, and echocardiography at baseline and at 14 days. From both ECGs we cal- 
culated the Selvester CIRS score, the sum of ST segment elevation and the number of 
neaative T waves in leads I, avL. VI-V6. Left ventricular eiection fraction ILVEF) and inf- 
arct segment length were assessed by echocardiography. Results: Diabetics (n=56, 
20.6%) were similar to non-diabetics (n=216. 79.4%) with resoect to initial and 14-dav 
Infarct size es evidenced by maximal CK, ejection fraction and infarct segment length 
(Table). However, diabetics demonstrated a higher Killip class, greater QRS score at 
baseline and predlscharge and fewer negative T waves on predischarge ECG, even after 
excluding patients with prior myocardial infarction (n=43, 16%). Conclusion: Diabetes 
may modify the clinical and electrocardiographic response to myocardial infarction inde- 
pendently of infarct size or ventricular function. 
Age, yr 
Killip Class >I, % 
Maximal CK, mU/mL 
Baseline LVEF. % 
Baseline Infarct Seyment Length, % 
Day 14 LVEF, % 
Day 14 Infarct Segment Length, % 
Baseline Sum ST Elevation, mm 
Diabetics Non-Diabetics P 
(n=56) (n=216) VSIUS 
60.8 * 10.9 59.6 * 13.1 0.5 
34% 19% 0.01 
2593 * 1887 2484 f 2012 0.71 
51.6 * 10.1 52.2 f. 9.4 0.67 
27.2 * 9.8 25.8 f 11 .O 0.36 
54.5 * 10.3 56.5 * 8.9 0.14 
20.6 * 12.2 17.9 * 13.0 0.16 
11.5 * 9.2 10.5 * 7.9 0.44 
Baseline Number Negative T waves 0.7 f 1.4 0.8 f 3.2 0.85 
1068A-MP Moderated Poster Baseline QRS Score 4.3 * 2.9 3.4 * 2.6 0.03 
Session...Hyperglycemia and Diabetes in Predischarge Sum ST Elevation, mm 4.5 f 3.0 4.6 f 3.3 0.9 
Acute Coronary Syndromes II Predischarge Number Negative T 1.4* 1.7 2.6 * 2 2 0.001 
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1068A-MP-203Acute Hyperglycemia Abolishes lschemic 
Preconditioning: A Possible Mechanism for Adverse 
Outcome of Patients With Acute Myocardial Infarction 
and Acute Hyperglycemia 
Masaharu Ishihara, lchiro Inoue, Takuji Kawagoe, Yuji Shimatani, Satoshi Kurisu, Kenji 
Nishioka. Takashi Umemura, Shuji Nakamura, Masashi Yoshida, Hiroshima City 
Hospital, Hiroshima, Japan 
Background. Acute hyperglycemia has been shown to be an independent predictor of 
adverse outcome after acute myocardial Infarction (AMI). Prodromal anglna occurring 
shortly before the onset of AMI has cardioprotective effect by the mechanism of ischemic 
precondltloning. lschemic preconditioning is promoted by opening of mitochondrial K,, 
Predlscharge QRS Score 5.2 * 3.1 4.0 r 2.5 0.01 
3:30 p.m. 
1068A-MP-205 Impact of Known and Newly Diagnosed Diabetes 
Mellitus After a Myocardial Infarction 
Davtd Aauilar, Scott D. Solomon, Lars Kober, Jean-Luclen Rouleau, Hicham Skali, John 
J. McMurray, Gary S. Francis, Marc Hems. Rafael Diaz, Yuri N. Belenkov, Sergei 
Varshavsky, Jeffrey D. Leimberger, Robert M. Califf. Marc A. Pfeffer, Brigham 8 
Women’s Hospital, Boston, MA 
Background Diabetes mellitus (DM) is associated with adverse outcomes in patients 
(pts) presenting with an acute myocardial infarction (AMI). but little IS known of the risk of 
newly diagnosed DM. 
Methods The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial identified 
14,808 pts with an AMI complicated by either clinical or radiologic signs of heart failure 
and/or evidence of left ventricular (LV) systolic dysfunction. Assessment of diabetic sts- 
